1. Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we know. Issue 6 (December 2019) Authors: Filetti, Marco; Giusti, Raffaele; Di Napoli, Arianna; Iacono, Daniela; Marchetti, Paolo Journal: Tumori Issue: Volume 105:Issue 6(2019) Page Start: NP48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of tumor site on the prognosis of small bowel adenocarcinoma. Issue 6 (December 2019) Authors: Falcone, Rosa; Romiti, Adriana; Filetti, Marco; Roberto, Michela; Righini, Riccardo; Botticelli, Andrea; Pilozzi, Emanuela; Ghidini, Michele; Pizzo, Claudio; Mazzuca, Federica; Marchetti, Paolo Journal: Tumori Issue: Volume 105:Issue 6(2019) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events. (March 2020) Authors: Cortellini, Alessio; Bersanelli, Melissa; Santini, Daniele; Buti, Sebastiano; Tiseo, Marcello; Cannita, Katia; Perrone, Fabiana; Giusti, Raffaele; De Tursi, Michele; Zoratto, Federica; Marconcini, Riccardo; Russano, Marco; Zeppola, Tea; Anesi, Cecilia; Filetti, Marco; Marchetti, Paolo; Botticelli... Journal: European journal of cancer Issue: Volume 128(2020) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study. (July 2020) Authors: Nigro, Olga; Pinotti, Graziella; De Galitiis, Federica; Di Pietro, Francesca Romana; Giusti, Raffaele; Filetti, Marco; Bersanelli, Melissa; Lazzarin, Alessandro; Bordi, Paola; Catino, Annamaria; Pizzutilo, Pamela; Galetta, Domenico; Marchetti, Paolo; Botticelli, Andrea; Scagnoli, Simone; Russano,... Journal: European journal of cancer Issue: Volume 134(2020) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC. Issue 4 (31st March 2021) Authors: Rossi, Alessandro; Filetti, Marco; Taurelli Salimbeni, Beatrice; Piras, Marta; Rizzo, Francesco; Giusti, Raffaele; Marchetti, Paolo Journal: Cancer reports Issue: Volume 4:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study. Issue 6 (1st February 2021) Authors: Cortellini, Alessio; De Giglio, Andrea; Cannita, Katia; Cortinovis, Diego L.; Cornelissen, Robin; Baldessari, Cinzia; Giusti, Raffaele; D'Argento, Ettore; Grossi, Francesco; Santoni, Matteo; Catino, Annamaria; Berardi, Rossana; Sforza, Vincenzo; Rossi, Giovanni; Antonuzzo, Lorenzo; Di Noia, Vince... Journal: Thoracic cancer Issue: Volume 12:Issue 6(2021) Page Start: 880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis. (May 2022) Authors: Lombardi, Pasquale; Filetti, Marco; Falcone, Rosa; Di Bidino, Rossella; Iacovelli, Roberto; Ciccarese, Chiara; Bria, Emilio; Tortora, Giampaolo; Scambia, Giovanni; Daniele, Gennaro Journal: Cancer treatment reviews Issue: Volume 106(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study. (22nd February 2019) Authors: Cortellini, Alessio; Buti, Sebastiano; Santini, Daniele; Perrone, Fabiana; Giusti, Raffaele; Tiseo, Marcello; Bersanelli, Melissa; Michiara, Maria; Grassadonia, Antonino; Brocco, Davide; Tinari, Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Marconcini, Riccardo; Malorgio, Francesco;... Journal: Oncologist Issue: Volume 24:Number 6(2019) Page Start: e327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Issue 12 (December 2021) Authors: Pinato, David J; Tabernero, Josep; Bower, Mark; Scotti, Lorenza; Patel, Meera; Colomba, Emeline; Dolly, Saoirse; Loizidou, Angela; Chester, John; Mukherjee, Uma; Zambelli, Alberto; Dalla Pria, Alessia; Aguilar-Company, Juan; Ottaviani, Diego; Chowdhury, Amani; Merry, Eve; Salazar, Ramon; Bertuzzi... Journal: Lancet oncology Issue: Volume 22:Issue 12(2021) Page Start: 1669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. Issue 4 (7th April 2021) Authors: Cortellini, Alessio; Di Maio, Massimo; Nigro, Olga; Leonetti, Alessandro; Cortinovis, Diego L; Aerts, Joachim GJV; Guaitoli, Giorgia; Barbieri, Fausto; Giusti, Raffaele; Ferrara, Miriam G; Bria, Emilio; D'Argento, Ettore; Grossi, Francesco; Rijavec, Erika; Guida, Annalisa; Berardi, Rossana; Torni... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗